pegylated interferon alpha 2a

DRUG3 trials

Sponsors

French National Agency for Research on AIDS and Viral Hepatitis, Amr Hafez, Arrowhead Pharmaceuticals

Conditions

Chronic Hepatitis CHIV InfectionsHepatitis BHepatitis CHepatitis D

Phase 2

Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients

CompletedNCT00196586

French National Agency for Research on AIDS and Viral HepatitisChronic Hepatitis C, HIV Infections

Start: 2003-04-30End: 2006-11-30Target: 75Updated: 2007-11-16

Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)

TerminatedNCT02577029

Arrowhead PharmaceuticalsHepatitis B, Hepatitis D

Start: 2015-12-31End: 2016-12-31Updated: 2026-01-13

Phase 4

Comparison of Pegasys Versus Peg-Intron for Treatment of Chronic Hepatitis C Genotype 4

CompletedNCT00502099

Amr HafezHepatitis C

Start: 2006-01-31End: 2009-05-31Updated: 2012-10-23